« Back
Home /
Ruplizumab

Ruplizumab

Item no.	TMO-T76825-5mg
Manufacturer	TargetMol
CASRN	220651-94-5
Amount	5 mg
Quantity options	10 mg 1 mg 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BG9588,BG 9588,Anti-Human CD40L Recombinant Antibody
Shipping Condition	Cool pack
Available
Manufacturer - Targets	TNF
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	566, 63
Description	Ruplizumab (BG 9588) is a humanized IgG1κ-like monoclonal antibody against CD40L. Ruplizumab is used in the study of neurological and immune system disorders.
Pathways	Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T76825-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question